Skei Oncotherapeutics Private Limited - Company Profile

It is a research & development private limited company based in Madurai, Tamil Nadu, India, established in 2021.
2021 Madurai, Tamil Nadu, India Active
Last Updated:
About Skei Oncotherapeutics Private Limited

Skei Oncotherapeutics Private Limited, a active private limited company, was established on 15 March 2021 in Madurai, Tamil Nadu, India. Engaging in social science research within the research & development sector, it holds CIN: U73200TN2021PTC142058. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹2.00 Cr and a paid-up capital of ₹0.10 M.

Its leadership includes Subburaj Magalakshmi (Director), Muthuraj Prakash (Director), Kesavan Venkitasamy (Additional Director). It is based at Plot No.184,S.R.V Nagar Thiruparankundram, Madurai, Tamil Nadu, 625005.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U73200TN2021PTC142058

  • Registration Number

    142058

  • Incorporation Date

    15 March 2021

  • Authorized Capital

    ₹2.00 Cr

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Chennai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 2.00 Cr
  • Paid Up Capital ₹ 0.10 M
  • Company Age 4 Year, 11 Months
Company report

Skei Oncotherapeutics Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Skei Oncotherapeutics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Skei Oncotherapeutics Private Limited?
Current Directors
Name Designation Appointment Date Status
Subburaj Magalakshmi Director 15 Mar 2021 Current
Muthuraj Prakash Director 15 Mar 2021 Current
Kesavan Venkitasamy Additional Director 07 Dec 2021 Current
Samy Durai Jayakumar Additional Director 10 Dec 2021 Current
Priyanka Ponnusamy Additional Director 10 Dec 2021 Current
Ram Vishwakarma Asrey Additional Director 07 Dec 2021 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Skei Oncotherapeutics.

Enhance accessibility to Skei Oncotherapeutics's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Skei Oncotherapeutics revenue growth over time
Skei Oncotherapeutics profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Skei Oncotherapeutics?

Unlock access to Skei Oncotherapeutics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Skei Oncotherapeutics?

Skei Oncotherapeutics has a workforce of 0 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Skei Oncotherapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Skei Oncotherapeutics's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Skei Oncotherapeutics
Recent Activity within the Organization
  • Director Appointment

    Samy Durai Jayakumar was appointed as a Additional Director was appointed as a Additional Director on 10 Dec 2021 & has been associated with this company since 4 years 2 months . was recorded as a recent event.

  • Director Appointment

    Priyanka Ponnusamy was appointed as a Additional Director was appointed as a Additional Director on 10 Dec 2021 & has been associated with this company since 4 years 2 months . was recorded as a recent event.

  • Director Appointment

    Progress on Kesavan Venkitasamy was appointed as a Additional Director was appointed as a Additional Director on 07 Dec 2021 & has been associated with this company since 4 years 2 months . was documented.

  • Director Appointment

    Ram Vishwakarma Asrey was appointed as a Additional Director was appointed as a Additional Director on 07 Dec 2021 & has been associated with this company since 4 years 2 months . was recorded as a recent event.

  • Director Appointment

    The activity Subburaj Magalakshmi was appointed as a Director was appointed as a Director on 15 Mar 2021 & has been associated with this company since 4 years 11 months . was completed.

  • Company Incorporation

    The activity Skei Oncotherapeutics Private Limited was registered on 15 Mar 2021 with Roc Chennai & aged 4 years 11 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Skei Oncotherapeutics Private Limited?

The CIN of Skei Oncotherapeutics Private Limited is U73200TN2021PTC142058.

Where is Skei Oncotherapeutics Private Limited headquartered?

Skei Oncotherapeutics Private Limited is headquartered at Plot No.184,S.R.V Nagar Thiruparankundram, Madurai, Tamil Nadu, 625005.

When was Skei Oncotherapeutics Private Limited incorporated?

Skei Oncotherapeutics Private Limited was incorporated on 15 March 2021.

Who are the current directors of Skei Oncotherapeutics Private Limited?
What is the primary industry of Skei Oncotherapeutics Private Limited?

The primary industry of Skei Oncotherapeutics Private Limited is Research & Development.

Is Skei Oncotherapeutics Private Limited a listed company?

Skei Oncotherapeutics Private Limited is unlisted.

What is the capital structure of Skei Oncotherapeutics Private Limited?

The authorized capital of Skei Oncotherapeutics Private Limited is ₹2.00 Cr, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available